CD24 expression has a prognostic impact in breast carcinoma

被引:43
作者
Athanassiadou, Pauline [1 ]
Grapsa, Dimitra [1 ]
Gonidi, Maria [1 ]
Athanassiadou, Anna-Maria [1 ]
Tsipis, Angelos [1 ]
Patsouris, Efstratios [1 ]
机构
[1] Univ Athens, Sch Med, Dept Pathol 1, Cytol Unit, GR-11527 Athens, Greece
关键词
Apoptosis; BAG-1; Breast; Carcinoma; CD24; APOPTOTIC PROTEIN BAG-1; P-SELECTIN; CELL CARCINOMAS; TUMOR-MARKER; IN-SITU; CANCER; SURVIVAL; DIFFERENTIATION; IDENTIFICATION; ANTIGEN;
D O I
10.1016/j.prp.2009.01.008
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We investigated the prognostic significance of BAG-1 and CD24 in invasive breast carcinomas. Seventy cases of invasive breast carcinoma were studied immunocytochemically for the expression of BAG-1 and CD24. The results were correlated with several prognostic parameters, including 5-year survival. Univariate analysis showed a significant correlation of BAG-1 and CD24 overall positive staining with several adverse prognostic parameters, such as increased stage (p<0.0001), tumor grade 3 (p = 0.016 and p = 0.02, respectively), positive lymph nodes (p<0.0001), and increased tumor size (p<0.0001). Similar results were found for BAG-1 nuclear staining, as well as for positive cytoplasmic CD24 expression. Both of our markers studied had a significant, negative effect on survival. Multivariate analysis further revealed an independent prognostic impact for CD24 overall staining. The results of our study showed that overall cytoplasmic and especially nuclear BAG-1 expression, as well as overall and cytoplasmic CD24 expression, correlates with adverse prognostic parameters. An independent prognostic value for overall CD24 staining was also demonstrated. (C) 2009 Elsevier GmBH. All rights reserved.
引用
收藏
页码:524 / 533
页数:10
相关论文
共 44 条
  • [1] CD24 mediates rolling of breast carcinoma cells on P-selectin
    Aigner, S
    Ramos, CL
    Hafezi-Moghadam, A
    Lawrence, MB
    Friederichs, J
    Altevogt, P
    Ley, K
    [J]. FASEB JOURNAL, 1998, 12 (12) : 1241 - 1251
  • [2] HEAT-STABLE ANTIGEN (MOUSE CD24) SUPPORTS MYELOID CELL-BINDING TO ENDOTHELIAL AND PLATELET P-SELECTIN
    AIGNER, S
    RUPPERT, M
    HUBBE, M
    SAMMAR, M
    STHOEGER, Z
    BUTCHER, EC
    VESTWEBER, D
    ALTEVOGT, P
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (10) : 1557 - 1565
  • [3] Prospective identification of tumorigenic breast cancer cells
    Al-Hajj, M
    Wicha, MS
    Benito-Hernandez, A
    Morrison, SJ
    Clarke, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
  • [4] HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
    Bardelli, A
    Longati, P
    Albero, D
    Goruppi, S
    Schneider, C
    Ponzetto, C
    Comoglio, PM
    [J]. EMBO JOURNAL, 1996, 15 (22) : 6205 - 6212
  • [5] CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
    Bircan, Sema
    Kapucuoglu, Nilgun
    Baspinar, Sirin
    Inan, Gulsun
    Candir, Ozden
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2006, 202 (08) : 569 - 576
  • [6] HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
    Bozzetti, C
    Personeni, N
    Nizzoli, R
    Guazzi, A
    Flora, M
    Bassano, C
    Negri, F
    Martella, E
    Naldi, N
    Franciosi, V
    Cascinu, S
    [J]. CANCER CYTOPATHOLOGY, 2003, 99 (05): : 310 - 315
  • [7] Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2
    Clevenger, CV
    Thickman, K
    Ngo, W
    Chang, WP
    Takayama, S
    Reed, JC
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (05) : 608 - 618
  • [8] RISK-FACTORS FOR BREAST-CANCER BY ESTROGEN-RECEPTOR STATUS - A POPULATION-BASED CASE-CONTROL STUDY
    COOPER, JA
    ROHAN, TE
    CANT, ELM
    HORSFALL, DJ
    TILLEY, WD
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (01) : 119 - 125
  • [9] DROZ D, 1990, AM J PATHOL, V137, P895
  • [10] CD24 is a marker for human breast carcinoma
    Fogel, M
    Friederichs, J
    Zeller, Y
    Husar, M
    Smirnov, A
    Roitman, L
    Altevogt, P
    Sthoeger, ZM
    [J]. CANCER LETTERS, 1999, 143 (01) : 87 - 94